SHREIS SCALENE SCIENCES LLC



The Cytotron



Shreis Scalene Sciences LLC holds an exclusive, perpetual and irrevocable license for the manufacturing, marketing, distribution of the Cytotron device in the North and South American market including Mexico, Canada and the Caribbean.

Shreis has received the US FDA's BreakThrough Device (BTD) designation for Cancer.




PEDIATRIC VERSION OF THE CYTOTRON
USED IN THE PEDIATRIC CLINICAL STUDY AT
CHILDRENS HOSPITAL OF MEXICO



ROTATIONAL FIELD QUANTUM MAGNETIC RESONANCE (RFQMR) is the platform therapy proven for tissue regeneration and degeneration of tissue





About Us


Shreis.org

CYTOTRON
A PLATFORM TECHNOLOGY



REGENERATION

DEGENERATION

TARGETED DRUG DELIVERY


TECHNOLOGY RESOURCES

SHREIS SCALENE GROUP



11516 Darnestown Rd
Gaithersburg, MD 20878
USA